Alteration of the activity of the FBP/PFK substrate cycle and its effects on cofactor balances of ATP, NADH and NADPH may also be a mechanistic explanation for the recent discovery of the strong causative link between mutations affecting the FBP1 gene and renal cell carcinoma in humans. The gene discussed is FBP1; the disease is renal cell carcinoma.